The Effect of Troglitazone on Thermal Sensitivity in Uterine Cervix Cancer Cells

다국어 초록 (Multilingual Abstract)

Purpose: Troglitazone (TRO), a PPAR-γ agonist, can reduce heat shock protein (HSP) 70 and increase the antioxidant enzymes, such as superoxide dismutase (SOD) and catalase, which might affect thermal sensitivity. Here, we investigated whether TRO modifies thermal sensitivity in uterine cervical cancer cells, which is most commonly treated by hyperthermia (HT).
Materials and Methods: HeLa cells were treated with 5μM TRO for 24 hours before HT at 42oC for 1 hour. Cell survival was analyzed by clonogenic assay. The expression of HSPs was analyzed by Western blot. SOD and catalase activity was measured and reactive oxygen species (ROS) was measured using 2',7'-dichlorofluorescin diacetate and dihydroethidium.
Results: The decreased cell survival by HT was increased by preincubation with TRO before HT. Expression of HSP 70 was increased by HT however, it was not decreased by preincubation with TRO before HT. The decreased Bcl-2 expression by HT was increased by preincubation with TRO. SOD and catalase activity was increased by 1.2 and 1.3 times,respectively with TRO. Increased ROS by HT was decreased by preincubation with TRO.
Conclusion: TRO decreases thermal sensitivity through increased SOD and catalase activity, as well as scavenging ROS in HeLa cells.

참고문헌 (Reference)

• 1 최두호, "한국에서 자궁경부암 방사선치료의 Patterns of Care Study 진행을 위한 문헌 비교 연구" 대한방사선종양학회 23 (23): 61-70, 2005
• 2 Sankaranarayanan R, "Worldwide burden of gynaecological cancer: the size of the problem" 20 : 207-225, 2006
• 3 Wu L, "Troglitazone selectively inhibits glyoxalase I gene expression" 44 : 2004-2012, 2001
• 4 Davies GF, "Troglitazone reduces heat shock protein 70 content in primary rat hepatocytes by a ubiquitin proteasome independent mechanism" 48 : 119-126, 2003
• 5 Welbourne T, "Troglitazone induces a cellular acidosis by inhibiting acid extrusion in cultured rat mesangial cells" 282 : R1600-R1607, 2002
• 6 Inoue I, "Troglitazone has a scavenging effect on reactive oxygen species" 235 : 113-116, 1997
• 7 Saltiel AR, "Thiazolidinediones in the treatment of insulin resistance and type II diabetes" 45 : 1661-1669, 1996
• 8 Inoue I, "The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells" 50 : 3-11, 2001
• 9 Hildebrandt B, "The cellular and molecular basis of hyperthermia" 43 : 33-56, 2002
• 10 Rossi A, "Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer" 66 : 7678-7685, 2006
• 11 Calderwood SK, "Targeting HSP70-induced thermotolerance for design of thermal sensitizers" 18 : 597-608, 2002
• 12 Friday E, "Role of epidermal growth factor receptor (EGFR)-signaling versus cellular acidosis via Na+/H+ exchanger1(NHE1)-inhibition in troglitazone-induced growth arrest of breast cancer-derived cells MCF-7" 20 : 751-762, 2007
• 13 Vasanthan A, "Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency" 61 : 145-153, 2005
• 14 Franckena M, "Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients" 73 : 242-250, 2009
• 15 Katschinski DM, "Pivotal role of reactive oxygen species as intracellular mediators of hyperthermia-induced apoptosis" 275 : 21094-21098, 2000
• 16 Koeffler HP, "Peroxisome proliferator-activated receptor gamma and cancers" 9 : 1-9, 2003
• 17 Finkel T, "Oxidants, oxidative stress and the biology of ageing" 408 : 239-247, 2000
• 18 Boonstra J, "Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells" 337 : 1-13, 2004
• 19 Zhao QL, "Mechanism of cell death induction by nitroxide and hyperthermia" 40 : 1131-1143, 2006
• 20 Davies GF, "Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism" 62 : 1071-1079, 2001
• 21 Song CW, "Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment" 21 : 761-767, 2005
• 22 Girnun GD, "Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter" 16 : 2793-2801, 2002
• 23 Bruey JM, "Hsp27 negatively regulates cell death by interacting with cytochromec" 2 : 645-652, 2000
• 24 Beere HM, "Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome" 2 : 469-475, 2000
• 25 Wu C, "Heat shock transcription factors: structure and regulation" 11 : 441-469, 1995
• 26 He L, "Heat shock suppresses the permeability transition in rat liver mitochondria" 278 : 16755-16760, 2003
• 27 Kregel KC, "Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance" 92 : 2177-2186, 2002
• 28 Li GC, "Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia" 11 : 459-488, 1995
• 29 Arya R, "Heat shock genes:integrating cell survival and death" 32 : 595-610, 2007
• 30 Jung TI, "Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma" 97 : 365-373, 2005
• 31 Moncada S, "Does nitric oxide modulate mitochondrial energy generation and apoptosis?" 3 : 214-220, 2002
• 32 Xu Y, "Deleterious effects of acute treatment with a peroxisome proliferator-activated receptorgamma activator in myocardial ischemia and reperfusion in pigs" 52 : 1187-1194, 2003
• 33 Zee J, "Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group" 355 : 1119-1125, 2000
• 34 Dewey WC, "Cellular responses to combinations of hyperthermia and radiation" 123 : 463-474, 1977
• 35 Gorman AM, "Antioxidant-mediated inhibition of the heat shock response leads to apoptosis" 445 : 98-102, 1999
• 36 Campbell MJ, "A role for the PPARgamma in cancer therapy" 2008